Synergistic Action of Gefitinib and GSK41364A Simultaneously Loaded in Ratiometrically-Engineered Polymeric Nanoparticles for Glioblastoma Multiforme

Glioblastoma Multiforme is a deadly cancer of glial cells with very low survival rates. Current treatment options are invasive and have serious side effects. Single drug treatments make the tumor refractory after a certain period. Combination therapies have shown improvements in treatment responses...

Descripción completa

Detalles Bibliográficos
Autores principales: Velpurisiva, Praveena, Rai, Prakash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462915/
https://www.ncbi.nlm.nih.gov/pubmed/30875975
http://dx.doi.org/10.3390/jcm8030367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462915/
https://www.ncbi.nlm.nih.gov/pubmed/30875975
http://dx.doi.org/10.3390/jcm8030367

Ejemplares similares